André Nayer

619 total citations
22 papers, 413 citations indexed

About

André Nayer is a scholar working on Pharmacology, Psychiatry and Mental health and Experimental and Cognitive Psychology. According to data from OpenAlex, André Nayer has authored 22 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 12 papers in Psychiatry and Mental health and 9 papers in Experimental and Cognitive Psychology. Recurrent topics in André Nayer's work include Treatment of Major Depression (12 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (8 papers) and Schizophrenia research and treatment (6 papers). André Nayer is often cited by papers focused on Treatment of Major Depression (12 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (8 papers) and Schizophrenia research and treatment (6 papers). André Nayer collaborates with scholars based in Belgium, France and Austria. André Nayer's co-authors include Jean-Luc Evrard, L. Van Gaal, Marc D. Binder, André Scheen, C. Mertens, C. Serre, J. Peuskens, Michel Schittecatte, Patrick Papart and Pierre Fossion and has published in prestigious journals such as Endocrinology, Psychopharmacology and The International Journal of Neuropsychopharmacology.

In The Last Decade

André Nayer

20 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
André Nayer Belgium 12 251 206 87 73 66 22 413
Helen Jeffriess United States 8 158 0.6× 116 0.6× 51 0.6× 80 1.1× 38 0.6× 9 324
Stephen T.H. Sokolov Canada 11 149 0.6× 172 0.8× 56 0.6× 58 0.8× 58 0.9× 13 370
John Scott Carman United States 9 206 0.8× 171 0.8× 89 1.0× 138 1.9× 25 0.4× 15 464
J O Cole United States 8 353 1.4× 350 1.7× 147 1.7× 89 1.2× 81 1.2× 10 583
Joseph Stringfellow United States 7 482 1.9× 130 0.6× 61 0.7× 114 1.6× 39 0.6× 19 669
C.G.G. Link United Kingdom 8 500 2.0× 143 0.7× 29 0.3× 75 1.0× 50 0.8× 14 585
C. A. Gagiano South Africa 6 245 1.0× 144 0.7× 44 0.5× 57 0.8× 15 0.2× 18 384
Trisha L. Houser United States 8 406 1.6× 424 2.1× 236 2.7× 45 0.6× 121 1.8× 13 666
I Maany United States 12 132 0.5× 94 0.5× 57 0.7× 223 3.1× 34 0.5× 20 557
Didier Meulien United States 14 309 1.2× 144 0.7× 32 0.4× 108 1.5× 28 0.4× 25 606

Countries citing papers authored by André Nayer

Since Specialization
Citations

This map shows the geographic impact of André Nayer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Nayer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Nayer more than expected).

Fields of papers citing papers by André Nayer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Nayer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Nayer. The network helps show where André Nayer may publish in the future.

Co-authorship network of co-authors of André Nayer

This figure shows the co-authorship network connecting the top 25 collaborators of André Nayer. A scholar is included among the top collaborators of André Nayer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Nayer. André Nayer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nayer, André. (2011). Le statut de l’artiste. Cahiers de recherche sociologique. 23–41. 1 indexed citations
2.
Binder, Marc D., Guy De Backer, Dirk De Bacquer, D Van Eyck, & André Nayer. (2008). Metabole stoornissen en antipsychotica, drie jaar na de 'Belgische consensus'. 13(3). 1–6.
3.
Nayer, André, et al.. (2007). Troubles métaboliques associés aux antipsychotiques atypiques : consensus belge sur la conduite à tenir. L Encéphale. 33(2). 197–202. 19 indexed citations
4.
Nayer, André, et al.. (2007). Le droit à l'épanouissement de l'être humain au travail. Métamorphoses du droit social ?. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 2 indexed citations
5.
Nayer, André, E. Windhager, Irmansyah, et al.. (2005). Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone. Human Psychopharmacology Clinical and Experimental. 20(8). 573–581. 17 indexed citations
6.
Nayer, André, et al.. (2005). Belgian consensus on metabolic problems associated with atypical antipsychotics. International Journal of Psychiatry in Clinical Practice. 9(2). 130–137. 61 indexed citations
7.
Binder, Marc D., André Nayer, André Scheen, L. Van Gaal, & Joseph Peuskens. (2004). Conference report: Belgian consensus on metabolic problems associated with atypical antipsychotics. 11 indexed citations
8.
Nayer, André, E. Windhager, Irmansyah, et al.. (2003). Efficacy and tolerability of quetiapine in patients with schizophrenia switched from other antipsychotics. International Journal of Psychiatry in Clinical Practice. 7(1). 59–66. 31 indexed citations
9.
Nayer, André, Michel Schittecatte, Jean-Luc Evrard, et al.. (2002). Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety. The International Journal of Neuropsychopharmacology. 5(2). 115–20. 63 indexed citations
10.
Demyttenaere, Koen, et al.. (2002). Six month compliance with fluoxetine or paroxetine treatment in depressed outpatients. European Neuropsychopharmacology. 12. 208–208. 3 indexed citations
11.
Nayer, André, M. Ansseau, Hugo D’Haenen, et al.. (2002). An eight-week, open-label, uncontrolled, multicenter, Phase IV study of remission rates in outpatients and inpatients with major depression treated with venlafaxine. Current Therapeutic Research. 63(8). 475–485. 3 indexed citations
12.
Nayer, André, et al.. (2000). Symptom relief obtained with Venlafaxine versus fluoxetine in depressed patients with concomitant anxiety. European Neuropsychopharmacology. 10. 242–242. 1 indexed citations
13.
Ansseau, Marc, et al.. (1996). Controlled Comparison of Tianeptine, Alprazolam and Mianserin in the Treatment of Adjustment Disorders with Anxiety and Depression. Human Psychopharmacology Clinical and Experimental. 11(4). 293–298. 1 indexed citations
14.
Nayer, André, et al.. (1994). Controlled comparison of nefazodone and amitriptyline in major depressive inpatients. Psychopharmacology. 115(1-2). 254–260. 16 indexed citations
15.
Ansseau, M., Patrick Papart, Michel Bataille, et al.. (1994). Controlled comparison of milnacipran and fluoxetine in major depression. Psychopharmacology. 114(1). 131–137. 42 indexed citations
16.
Ansseau, M., et al.. (1993). A double-blind comparison of paroxetine and fluvoxamine in major depression. European Neuropsychopharmacology. 3(3). 323–324. 11 indexed citations
17.
Ansseau, Marc, R. von Frenckell, C. Mertens, et al.. (1991). Interest of a loading dose of milnacipran in endogenous depressive inpatients. European Neuropsychopharmacology. 1(2). 113–121. 19 indexed citations
18.
Ansseau, Marc, R. von Frenckell, C. Mertens, et al.. (1989). Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients. Psychopharmacology. 98(2). 163–168. 57 indexed citations
19.
Ansseau, M., R. von Frenckell, Patrick Papart, et al.. (1989). Controlled comparison of milnacipran (F2207) 200 mg and amitriptyline in endogenous depressive inpatients. Human Psychopharmacology Clinical and Experimental. 4(3). 221–227. 22 indexed citations
20.
Nayer, André, et al.. (1971). Thyroglobulin Uptake by Pig Thyroid Slices. Endocrinology. 88(2). 389–399. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helen Jeffriess Breakdown of academic impact, for papers by Stephen T.H. Sokolov Breakdown of academic impact, for papers by John Scott Carman Breakdown of academic impact, for papers by J O Cole Breakdown of academic impact, for papers by Joseph Stringfellow Breakdown of academic impact, for papers by C.G.G. Link Breakdown of academic impact, for papers by C. A. Gagiano Breakdown of academic impact, for papers by Trisha L. Houser Breakdown of academic impact, for papers by I Maany Breakdown of academic impact, for papers by Didier Meulien
Rankless by CCL
2026